3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.androgen insensitivity syndrome, non-human animalRecruitingPhase 32026-04-09NCT07520565
Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic StrokeAcute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorderRecruitingPhase 22025-12-12NCT07279493
Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunctioncardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorderRecruitingPhase 42025-11-25NCT07110415